Goldman Sachs Bonus Zert BAYN 26..../ DE000GQ7VQM5 /

5/24/2024 10:29:04 AM	Chg.+0.01	Bid10:00:37 PM	Ask10:00:37 PM	Underlying	Strike price	Expiration date	Option type
46.74EUR	+0.02%	- Bid Size: -	- Ask Size: -	BAYER AG NA O.N.	36.00 EUR	6/26/2024	Put

TeleTrader 5/14 Bayer's sales in Q1 at €13.7 billion, down 4.3%

GlobeNewswire 5/2 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...

GlobeNewswire 4/18 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...

GlobeNewswire 4/16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...

GlobeNewswire 4/11 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...

GlobeNewswire 4/9 AskBio Names Mansuo Shannon Chief Scientific Officer

GlobeNewswire 3/25 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...

GlobeNewswire 3/14 Bayer and Aignostics to collaborate on next generation precision oncology

GlobeNewswire 3/6 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...

TeleTrader 3/5 Bayer's Q4 sales at €11.9 billion

GlobeNewswire 3/4 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM

TeleTrader 3/4 Earnings preview: Bayer, Broadcom among those in calendar

GlobeNewswire 2/15 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust

GlobeNewswire 2/13 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...

GlobeNewswire 2/13 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure

TeleTrader 1/29 Bayer down over 5% after latest $2.25B Roundup ruling

TeleTrader 1/17 Bayer to cut jobs amid 'difficult situation'

GlobeNewswire 1/5 AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)

GlobeNewswire 1/4 AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary end...

GlobeNewswire 12/14/2023 Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Su...

GlobeNewswire 12/6/2023 NFWF Announces $4.1 Million in Grants to Conserve the Monarch Butterfly and Other Insect Pollinators

TeleTrader 11/20/2023 Bayer's stock slumps over 16% on study halt, Roundup ruling

GlobeNewswire 11/9/2023 Bayer and Recursion Focus Research Collaboration on Oncology

GlobeNewswire 11/9/2023 Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NV...

TeleTrader 11/8/2023 Bayer reports sales of €10.3 billion in Q3